Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,508
Closed -$403K 624
2020
Q2
$403K Hold
5,508
0.01% 416
2020
Q1
$403K Sell
5,508
-992
-15% -$74.9K 0.01% 416
2019
Q4
$572K Hold
6,500
0.02% 443
2019
Q3
$482K Hold
6,500
0.01% 506
2019
Q2
$552K Sell
6,500
-11,800
-64% -$947K 0.01% 484
2019
Q1
$1.57M Buy
+18,300
New +$1.49M 0.04% 321
2014
Q2
Sell
-4,900
Closed -$262K 980
2014
Q1
$262K Hold
4,900
0.01% 827
2013
Q4
$248K Buy
+4,900
New +$213K 0.01% 806

Other funds holding INCY

Barings's INCY Position: Q3 2020 in Review

Barings sold out of Incyte (INCY) in Q3 2020, closing a stake of 5,508 shares — an estimated $403K sold.

Barings first reported a position in INCY in Q4 2013 and held it in 8 quarters. The position peaked at $1.57M in Q1 2019. 500 funds tracked by Wall St. Rank hold INCY as of Q3 2020.

  • Barings reported no remaining Incyte position as of Q3 2020 after selling out during the quarter.
  • Barings sold 5,508 Incyte shares in Q3 2020, an estimated $403K.
  • Barings first reported a position in Incyte in Q4 2013 and held it in 8 quarters.
  • Barings's Incyte position peaked at $1.57M in Q1 2019.
  • 500 funds tracked by Wall St. Rank held Incyte as of Q3 2020.

Based on Barings's 13F filing for Q3 2020, filed 12 Nov 2020.